S1 kills MCF-7/ADR cells more than MCF-7 cells: A protective mechanism of endoplasmic reticulum stress

Biomedicine and Pharmacotherapy

Volumn 67, Issue 8, 2013, Pages 731-736

  Song, Ting ^a   Liang, Furong ^a   Zhang, Zhichao ^a   Liu, Yubo ^a   Sheng, Hongkun ^a   Xie, Mingzhou ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Apoptosis; BH3 mimetic; ER stress; MCF 7 ADR; PBcl 2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BH3 PROTEIN; CYTOCHROME C; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; MULTIDRUG RESISTANCE PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN IRE1; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL KILLING; CELL STRAIN MCF 7; CYTOSOL; DRUG EFFICACY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TARGET CELL; WESTERN BLOTTING;

APOPTOSIS; BH3 MIMETIC; ER STRESS; MCF-7/ADR; PBCL-2;

ACENAPHTHENES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM STRESS; HUMANS; IMMUNOPRECIPITATION; MCF-7 CELLS; PHOSPHORYLATION; PYRROLES;

EID: 84887613575     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.03.015     Document Type: Article

References (28)

1. Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002, 2:647-656.
2. Willis S.N., Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 2005, 17:617-625.
3. Fesik S.W. Insights into programmed cell death through structural biology. Cell 2000, 103:273-282.
4. Azmi A.S., Mohammad R.M. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. J Cell Physiol 2009, 218:13-21.
5. Zhang L., Ming L., Yu J. BH3 mimetics to improve cancer therapy: mechanisms and examples. Drug Resist Updat 2007, 10:207-217.
6. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature 2005, 435:677-681.
7. Oki Y., Copeland A., Hagemeister F., Fayad L.E., Fanale M., Romaguera J., et al. Experience with obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma. Blood 2012, 119:2171-2172.
8. Baggstrom M.Q., Qi Y., Koczywas M., Argiris A., Johnson E.A., Millward M.J., et al. A phaseII study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. J Thorac Oncol 2011, 6(10):1757-1760.
9. Shimada K., Tomita A., Minami Y., Abe A., Hind C.K., Kiyoi H., et al. CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737. Exp Hametol 2012, 40(9):724-737.
10. Akaqunduz O., Karaca B., Atmaca H., Uzunoqlu S., Karabulut B., Sanli U.A., et al. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment. J BUON 2010, 15(4):763-767.
11. Ahn J.H., Jang G.H., Lee M. Defective autophagy in multidrug resistant cells may lead to growth inhibition by BH3-mimetic gossypol. J Cell Physiol 2012, 10.1002/jcp.24305.
12. Stopeck A.T., Brown-Glaberman U., Wong H.Y., Park B.H., Barnato S.E., Gradishar W.J., et al. The role of targeted therapy and biomarkers in breast cancer treatment. Clin Exp Metastasis 2012, 29(7):807-819.
13. Li J., Xu L.Z., He K.L., Guo W.J., Zheng Y.H., Xia P., et al. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Breast Cancer Res 2001, 3:253-263.
14. Vickers P.J., Dickson R.B., Shoemaker R., Cowan K.H. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol Endocrinol 1988, 2(10):886-889.
15. Cho H.Y., Thomas S., Golden E.B., Gaffney K.J., Hofman F.M., Chen T.C., et al. Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. Cancer Lett 2009, 282(1):87-97.
16. Shore G.C., Papa F.R., Oakes S.A. Signalling cell death from the endoplasmic reticulum stress response. Curr Opin Cell Biol 2011, 23(2):143-149.
17. Wu J., Kaufman R.J. From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ 2006, 13(3):374-384.
18. Li Z., Wang N., Fang J., Huang J., Tian F., Li C., et al. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. Oncol Rep 2012, 27(6):1879-1886.
19. Ahn J.H., Lee M. Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2. Cancer Lett 2011, 310:188-197.
20. Zhang Z., Song T., Zhang T., Gao J., Wu G., An L., et al. A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1. Int J Cancer 2011, 128:1724-1735.
21. Zhang Z., Wu G., Xie F., Song T., Chang X. 3-thiomorpholin-8-oxo- 8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukaemia sequence 1 (Mcl-1): structure-based design and structure-activity relationship studies. J Med Chem 2011, 54:1101-1105.
22. Song T., Chang X., Zhang Z., Liu Y., Shen X. S1, a novel pan-BH3 mimetic, induces apoptosis in Mcl-1-overexpressing cells through Bak. J Pharmacol Sci 2012, 119(4):330-340.
23. Albershardt T.C., Salerni B.L., Soderquist R.S., Bates D.J., Pletnev A.A., Kisselev A.F., et al. Multiple BH3 mimetics antagonize antiapoptotic Mcl-1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA. J Biol Chem 2011, 286(28):24882-24895.
24. Zhong J.T., Xu Y., Yi H.W., Su J., Yu H.M., Xiang X.Y., et al. The BH mimetic S1 induces autophagy through ER stress and disruption of Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Lett 2012, 323(2):180-187.
25. Friquet B., Bulteau A.L., Petropoulos I. Mitochondrial protein quality control: implications in ageing. Biotechnol J 2008, 3(6):757-764.
26. Liu Y., Yang Y., Ye Y.C., Shi Q.F., Chai K., Tashiro S., et al. Activation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-Met inhibitor SU11274 in human lung cancer A549 cells. J Pharmacol Sci 2012, 118(4):423-432.
27. Konopleva M., Contractor R., Tsao T., Samudio I., Ruvolo P.P., Kitada S., et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukaemia. Cancer Cell 2006, 10:375-388.
28. Perez-Galan P., Roue G., Lopez-Guerra M., Nquyen M., Villamor N., Montserrat E., et al. BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells. Leukemia 2008, 22(9):1712-1720.